Search results
Jun 11, 2024 · Now, however, to address this knowledge gap, a research team led by Associate Professor Naoya Takayama from Chiba University, Japan, has recently developed a novel in vitro co-culture system that can accurately represent atherosclerosis, allowing for in-depth molecular analyses.
Jun 11, 2024 · Now, however, to address this knowledge gap, a research team led by Associate Professor Naoya Takayama and Professor Koutaro Yokote from Chiba University, Japan, and Professor Koji Eto, affiliated with Chiba University and Center for iPS Cell Research and Application, Kyoto University, has recently developed a novel in vitro co-culture system ...
Jun 11, 2024 · Dr. Naoya Takayama is currently an Associate Professor at the Graduate School of Medicine of Chiba University, Japan. His research mainly includes cell biology in relation to stem cells, covering...
Jun 13, 2024 · Led by Associate Professor Dr Naoya Takayama, the researchers developed a novel in vitro co-culture system that accurately represents atherosclerosis, enabling in-depth molecular analyses. The co-culture system uses induced pluripotent stem cells (iPSCs).
Jun 13, 2024 · News stories, articles and whitepapers referencing Dr Naoya Takayama (Chiba University) on Drug Target Review
Jun 10, 2024 · Naoya Takayama. Nature Communications 15, Article number: 4772 ( 2024 ) Cite this article. 1409 Accesses. 56 Altmetric. Metrics. Abstract. The underlying mechanisms of atherosclerosis, the...
Jun 17, 2024 · Naoya Takayama & Koji Eto. Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan. Atsushi Kaneda
